DAVIS GEORGE ERIC (EVP, Chief Legal Officer) sold 26.5% of their position (26.06K shares) of BIOMARIN PHARMACEUTICAL INC on the open market
Open‑market sale worth $1.60M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/26/2026ACC: 0001628280-26-012533
Officer· EVP, Chief Legal Officer
Since Feb 2026
-10.84K
Net shares
Net seller
$1.60M
Total sold
1
Open market trades
0B · 1S
4
Total transactions
15.22K acquired · 26.06K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+6.18K
Price / share
—
Trade value
—
% of position
7.4%
2/25/2026
83.29K→89.47K
Common Stock
Direct
Shares
+6.67K
Price / share
—
Trade value
—
% of position
7.5%
2/25/2026
89.47K→96.14K
Common Stock
Direct
Shares
+2.37K
Price / share
—
Trade value
—
% of position
2.5%
2/25/2026
96.14K→98.51K
Common Stock
Direct
Shares
−26.06K
Price / share
$61.36
Trade value
$1.60M
% of position
26.5%
2/26/2026
98.51K→72.45K
Total
Net shares
−10.84K
Net value
-$1.60M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/25/2026 | A · Award | +6.18K | — | — | 7.4% | 83.29K | 89.47K |
| Common Stock Direct | 2/25/2026 | A · Award | +6.67K | — | — | 7.5% | 89.47K | 96.14K |
| Common Stock Direct | 2/25/2026 | A · Award | +2.37K | — | — | 2.5% | 96.14K | 98.51K |
| Common Stock Direct | 2/26/2026 | S · Sale | −26.06K | $61.36 | $1.60M | 26.5% | 98.51K | 72.45K |
| Total | −10.84K | -$1.60M | ||||||
Derivative Transactions0
No derivative transactions reported